Supplementary Figure 2: Expression levels of KRAS, COPB2, NCOR1
and SPRY1 across the five colorectal adenocarcinoma cell lines available in TCGA's cBioPortal (www.cbioportal.org) [30, 31] . The expressions of COPB2 and NCOR1 have a much higher median than the KRAS expressions but wider standard deviation. SPRY1 has in average lower expressions than KRAS
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KRAS SLPs in literature or 'gold standard genes' (GSGs)
In order to retrieve the KRAS SLPs we searched PubMed, initially with the query "KRAS synthetic lethal". The result of the query, as of 17-03-2014, contained 28 papers, including KRAS SLPs in species different from human. Some of the retrieved studies detected drug di and gene gi combinations as KRAS SLPs [1] . This means that a gene gi is SLP of KRAS only under the presence of a specific drug di. To avoid missing any potential SLPs, the query was expanded to "RAS synthetic lethal". This resulted in 68 papers, including KRAS and other members of the Ras-family (HRAS, NRAS) SLPs as well. 
